| 000 | 014130000a22003130004500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 008 | 081214s2008 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aEng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.08.09.M.Sc.2008.Ma.P | ||
| 100 | 0 | _aMaha Ahmed Eltemamy | |
| 245 | 1 | 0 |
_aPharmacological study of some chemotherapeutic drugs in breast cancer patients / _cMaha Ahmed Eltemamy ; Supervised Helmy Moawad Sayed Ahmed , Ahmed M. Abdelwareth |
| 246 | 1 | 5 | _aدراسة دوائية لمختلف العقاقير الكيميائية المستخدمة فى علاج مرضى سرطان الثدى |
| 260 |
_aCairo : _bMaha Ahmed Eltemamy , _c2008 |
||
| 300 |
_a116P. : _bcharts ; _c25cm |
||
| 502 | _aThesis(M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmacology and Toxicology | ||
| 520 | _aThiis study is comparison between adnamycin a component of FAC regimen and epirubicin as a component of FEC regimen adriamycin together with other componenent of FAC therapy resulted in a significant decrease in white blood cells | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aBreast Cancer | |
| 653 | 4 | _aFAC | |
| 653 | 4 | _aFEC | |
| 700 | 0 |
_aAhmed Mohamed Abdelwareth , _eSupervisor |
|
| 700 | 0 |
_aHelmy Moawad Sayed Ahmed , _eSupervisor |
|
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSoheir _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c18650 _d18650 |
||